Klebanov, Boris
Alnylam Pharmaceuticals (United States)
2 papers on CoChatORCID 0000-0002-6969-6582
Most cited papers
- Verified
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
Whitehead, K. A., Dorkin, J. R., Vegas, A. J., Chang, P. H., Veiseh, O., Matthews, J., Fenton, O. S., Zhang, Y., Olejnik, K. T., Yesilyurt, V., et al. (2014) · Nature Communications
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 615
- Verified
Cutting Edge: Hypoxia-Inducible Factor 1α and Its Activation-Inducible Short Isoform I.1 Negatively Regulate Functions of CD4+ and CD8+ T Lymphocytes
Lukashev, D., Klebanov, B., Kojima, H., Grinberg, A., Ohta, A., Berenfeld, L., Wenger, R. H., Ohta, A., & Sitkovsky, M. (2006) · The Journal of Immunology
Cancer, Hypoxia, and MetabolismT-cell and B-cell Immunology
Cited by 208
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free